MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeProduct DevelopmentDesign & Engineering2015 MDEA Finalists: DuoResp Spiromax

2015 MDEA Finalists: DuoResp Spiromax

DuoResp Spiromax   DuoResp Spiromax, manufactured by Teva Pharmaceuticals Europe (UK) is a dry-powder inhaler for existing medicines for asthma and COPD that uses an intuitive design to minimize the training required for patients and provide consistent drug delivery across inspiratory flow rates.

DuoResp Spiromax

 

DuoResp Spiromax, manufactured by Teva Pharmaceuticals Europe (UK) is a dry-powder inhaler for existing medicines for asthma and COPD that uses an intuitive design to minimize the training required for patients and provide consistent drug delivery across inspiratory flow rates.

Supply/design credit: Gerresheimer  
          
TAGS: News
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
IMEast.png
Medical Design & Manufacturing (MD&M) East 2023
Amanda Pedersen, senior editor of MD+DI, headshot and quote about medtech engineering and R&D
Your Medtech Project Flopped, Now What?
Mar 27, 2023
IMG_2023-3-21-040530.png
Did Someone Call for a Supplier Quality Engineer?
Mar 21, 2023
IMG_2023-3-9-111517.jpg
There's More Than Meets The Eye with the Luna Surgical Robot
Mar 09, 2023